Kazir, Israel

Inbal Dubiner

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inbal Dubiner: Innovator in Medical Technology

Introduction

Inbal Dubiner is a prominent inventor based in Kazir, Illinois, known for her significant contributions to medical technology. With a total of two patents to her name, she has developed innovative systems that enhance medical analysis and tissue assessment.

Latest Patents

Inbal Dubiner's latest patents include a medical analysis system for mid-field signal extraction and an apparatus for assessing scarring of cardiac tissue. The mid-field signal extraction system involves a catheter equipped with sensing electrodes that contact tissue surfaces to receive electrical signals. This system processes these signals to compute a mid-field signal that represents electrical activity beneath the tissue surface. The scar assessment apparatus consists of a probe with electrodes that sense voltages in cardiac tissue. The processor analyzes these voltages to create a triangular mesh representing the tissue surface and assesses the degree of scarring by comparing the sensed voltages to predefined ranges.

Career Highlights

Inbal Dubiner works at Biosense Webster Ltd., where she applies her expertise in medical technology to develop innovative solutions. Her work focuses on improving diagnostic methods and enhancing patient care through advanced medical devices.

Collaborations

Inbal collaborates with talented professionals in her field, including Shiran Eliyahu and Vladimir Rubinstein. These collaborations contribute to the development of cutting-edge medical technologies.

Conclusion

Inbal Dubiner's work exemplifies the intersection of innovation and healthcare, showcasing her commitment to advancing medical technology. Her patents reflect her dedication to improving patient outcomes through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…